Who owns Kyverna Therapeutics, Inc.?
- CUSIP Number: 501976104
Tip: Access positions for across all investors
Analyze quarterly positions in Kyverna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kyverna Therapeutics stock
Who bought or sold Kyverna Therapeutics, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vida Ventures Advisors | 4.5M | $112M | 100% | Mar 2024 |
|
| Northpond Ventures | 3.3M | $81M | 100% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 3.2M | $79M | 100% | Mar 2024 |
|
| Deerfield Management Company | 1.5M | $36M | 100% | Mar 2024 |
|
| Jennison Associates | 1.4M | $35M | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 930k | $23M | 100% | Mar 2024 |
|
| Insight Holdings | 913k | $23M | 100% | Mar 2024 |
|
| Commodore Capital | 912k | $23M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 845k | $21M | 100% | Mar 2024 |
|
| BlackRock | 750k | $19M | 100% | Mar 2024 |
|
| Millennium Management | 695k | $17M | 100% | Mar 2024 |
|
| Henderson Group | 607k | $15M | 100% | Mar 2024 |
|
| Adage Capital Partners GP | 575k | $14M | 100% | Mar 2024 |
|
| Citadel Advisors | 531k | $13M | 100% | Mar 2024 |
|
| Logos Global Management | 500k | $12M | 100% | Mar 2024 |
|
| Franklin Resources | 461k | $11M | 100% | Mar 2024 |
|
| EcoR1 Capital | 450k | $11M | 100% | Mar 2024 |
|
| Cormorant Asset Management | 440k | $11M | 100% | Mar 2024 |
|
| Woodline Partners | 393k | $9.8M | 100% | Mar 2024 |
|
| Vanguard Group | 264k | $6.6M | 100% | Mar 2024 |
|
| Avidity Partners Management | 202k | $5.0M | 100% | Mar 2024 |
|
| Artal Group | 200k | $5.0M | 100% | Mar 2024 |
|
| Rock Springs Capital Management | 179k | $4.4M | 100% | Mar 2024 |
|
| Geode Capital Management | 172k | $4.3M | 100% | Mar 2024 |
|
| Cutter Capital Management | 167k | $4.1M | 100% | Mar 2024 |
|
| Marshall Wace | 156k | $3.9M | 100% | Mar 2024 |
|
| Casdin Capital | 150k | $3.7M | 100% | Mar 2024 |
|
| Perceptive Advisors | 150k | $3.7M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 150k | $3.7M | 100% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 150k | $3.7M | 100% | Mar 2024 |
|
| Ubs Global Asset Management Americas | 106k | $2.6M | 100% | Mar 2024 |
|
| LMR Partners | 105k | $2.6M | 100% | Mar 2024 |
|
| Blackstone Group | 100k | $2.5M | 100% | Mar 2024 |
|
| Pictet Asset Management Holding SA | 100k | $2.5M | 100% | Mar 2024 |
|
| Squarepoint Ops | 88k | $2.2M | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 85k | $2.1M | 100% | Mar 2024 |
|
| Arrowpoint Asset Management | 70k | $1.7M | 100% | Mar 2024 |
|
| Qube Research & Technologies | 69k | $1.7M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 65k | $1.6M | 100% | Mar 2024 |
|
| Point72 | 61k | $1.5M | 100% | Mar 2024 |
|
| Citigroup | 60k | $1.5M | 100% | Mar 2024 |
|
| Paradigm Biocapital Advisors | 50k | $1.2M | 100% | Mar 2024 |
|
| Hudson Bay Capital Management | 50k | $1.2M | 100% | Mar 2024 |
|
| Barclays | 43k | $1.1M | 100% | Mar 2024 |
|
| Polar Securities | 40k | $994k | 100% | Mar 2024 |
|
| Morgan Stanley | 40k | $992k | 100% | Mar 2024 |
|
| Laurion Capital Management | 38k | $932k | 100% | Mar 2024 |
|
| Jane Street | 37k | $920k | 100% | Mar 2024 |
|
| Ameriprise Financial | 37k | $909k | 100% | Mar 2024 |
|
| Northern Trust | 29k | $715k | 100% | Mar 2024 |
|
| Discovery Capital Management | 25k | $621k | 100% | Mar 2024 |
|
| UBS Group | 25k | $619k | 100% | Mar 2024 |
|
| Point72 Asset Management | 21k | $519k | 100% | Mar 2024 |
|
| Two Sigma Investments | 21k | $518k | 100% | Mar 2024 |
|
| Davidson Kempner Capital Management | 20k | $495k | 100% | Mar 2024 |
|
| Skandinaviska Enskilda Banken AB | 17k | $418k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 17k | $415k | 100% | Mar 2024 |
|
| Bank of America Corporation | 13k | $331k | 100% | Mar 2024 |
|
| Susquehanna International | 13k | $325k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 12k | $296k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 11k | $284k | 100% | Mar 2024 |
|
| Point72 Asia | 10k | $252k | 100% | Mar 2024 |
|
| Greenland Capital Management | 10k | $248k | 100% | Mar 2024 |
|
| Sofinnova Ventures | 10k | $248k | 100% | Mar 2024 |
|
| Legal & General Group | 9.6k | $238k | 100% | Mar 2024 |
|
| Diametric Capital | 9.3k | $231k | 100% | Mar 2024 |
|
| Tudor Investment Corporation | 8.5k | $211k | 100% | Mar 2024 |
|
| DekaBank Deutsche Girozentrale | 7.5k | $181k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 2.8k | $69k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 2.0k | $50k | 100% | Mar 2024 |
|
| Tower Research Capital | 766.00 | $19k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 183.00 | $5.0k | 100% | Mar 2024 |
|
| Brian McDonald | 63.00 | $1.6k | 100% | Mar 2024 |
|
| Washington Trust Advisors | 60.00 | $1.5k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 4.00 | $0 | 100% | Mar 2024 |
|